About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Vafseo Outcomes In-Center Experience | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingPhase 3NCT06520826

Vafseo Outcomes In-Center Experience

This trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment ...

Lead sponsor: USRC Kidney Research•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

USRC Kidney Research

Collaborators

Akebia Therapeutics

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult patients greater than or equal to 18 years of age.
•Receiving outpatient in-center hemodialysis at least three times per week for end-stage kidney disease.
•Currently prescribed or eligible for erythropoiesis-stimulating agent based on approved facility policy
•Understands the procedures and requirements of the study and provides written informed consent and authorization for protected health information disclosure.

Exclusion Criteria

•Contraindication to receive vadadustat or any of its known constituents per USPI.
•Cirrhosis or active, acute liver disease. Concomitant use of any hypoxia-inducible factor prolyl-hydroxylases or OAT1/OAT3 inhibitors (probenacid, rifampicin, gemfibrozil, or teriflunomide).
•Unable to comply with study requirements or in the opinion of a healthcare provider or a member of the central study team, not clinically stable to participate in the study.
•Pregnant at time of consent (per subject self-report).

Related studies

RECRUITINGPhase 4

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

NCT05515367 · Chronic Kidney Diseases, Anemia of Chronic Kidney Disease

RECRUITINGPhase 3

A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT06466785 · Anemia of Chronic Kidney Disease

Active Not RecruitingPhase 3

To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis

NCT06901505 · Anemia of Chronic Kidney Disease

WITHDRAWNPhase 3

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents

NCT05082584 · Anemia of Chronic Kidney Disease

Not Yet RecruitingPhase 3

Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients

NCT06352138 · Anemia of Chronic Kidney Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 10, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE3

Enrollment2,200

Start dateNov 2024

Last updatedMar 10, 2026

Condition

Anemia of Chronic Kidney Disease

Locations shown

USRC Kidney Research

Lone Tree, Colorado

Nephrology and Hypertension Specialists, PC

Dalton, Georgia

US Renal Care - Gallup

Gallup, New Mexico

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions